Yahoo
HKSE - Delayed Quote HKD

Kintor Pharmaceutical Limited (9939.HK)

1.350 -0.090 (-6.25%)
At close: October 30 at 4:08:06 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
78,738
32,682
5,000
0
0
Cost of Revenue
44,838
24,643
9,730
42,229
0
Gross Profit
33,900
8,039
-4,730
-42,229
0
Operating Expense
207,001
181,341
148,405
1,023,582
968,819
Operating Income
-173,101
-173,302
-153,135
-1,065,811
-968,819
Net Non Operating Interest Income Expense
-3,773
-3,836
-5,068
3,387
-1,305
Pretax Income
-198,219
-202,959
-155,274
-1,068,861
-953,284
Tax Provision
-5,598
-2,852
18
-8,041
1,085
Net Income Common Stockholders
-192,621
-200,107
-155,292
-1,060,820
-954,369
Diluted NI Available to Com Stockholders
-192,621
-200,107
-155,292
-1,060,820
-954,369
Basic EPS
-0.40
-0.44
-0.36
-2.47
-2.53
Diluted EPS
-0.40
-0.44
-0.36
-2.47
-2.53
Basic Average Shares
479,427
449,773
430,724
429,069
376,566
Diluted Average Shares
479,427
449,773
430,724
429,069
376,566
Total Operating Income as Reported
-200,275
-199,781
-144,568
-1,059,223
-944,529
Rent Expense Supplemental
--
--
--
682
1,217
Total Expenses
251,839
205,984
158,135
1,065,811
968,819
Net Income from Continuing & Discontinued Operation
-192,621
-200,107
-155,292
-1,060,820
-954,369
Normalized Income
-167,028.768
-174,188.402
-155,987.250
-1,058,691.137
-955,407
Interest Income
18
108
4,209
13,077
6,882
Interest Expense
3,791
3,944
9,277
9,690
8,187
Net Interest Income
-3,773
-3,836
-5,068
3,387
-1,305
EBIT
-194,428
-199,015
-145,997
-1,059,171
-945,097
EBITDA
-185,474
-165,802
-128,370
-1,040,195
-926,709
Reconciled Cost of Revenue
44,838
24,643
9,730
42,229
0
Reconciled Depreciation
8,954
33,213
17,627
18,976
18,388
Net Income from Continuing Operation Net Minority Interest
-192,621
-200,107
-155,292
-1,060,820
-954,369
Total Unusual Items Excluding Goodwill
-26,336
-26,288
927
-2,145
1,384
Total Unusual Items
-26,336
-26,288
927
-2,145
1,384
Normalized EBITDA
-159,138
-139,514
-129,297
-1,038,050
-928,093
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-743.768
-369.402
231.750
-16.137
346
12/31/2022 - 5/22/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: